LXRX - Lexicon: Beaten Down Stock High Risk-Reward Situation Ahead May, 31 2022 11:00 AM Lexicon Pharmaceuticals Inc. Lexicon has not been lucky with the FDA. However, there are reasons, discussed below, which make me see a special situation here. It may not be a bad idea to take the plunge. For further details see: Lexicon: Beaten Down Stock, High Risk-Reward Situation Ahead